G
Gregory Braden
Researcher at Baystate Medical Center
Publications - 91
Citations - 4124
Gregory Braden is an academic researcher from Baystate Medical Center. The author has contributed to research in topics: Hemodialysis & Renal function. The author has an hindex of 27, co-authored 90 publications receiving 3798 citations. Previous affiliations of Gregory Braden include Western New England University & University of Iowa.
Papers
More filters
Journal ArticleDOI
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial
Laura M. Dember,Gerald J. Beck,Michael Allon,James A. Delmez,Bradley S. Dixon,Arthur Greenberg,Jonathan Himmelfarb,Miguel A. Vazquez,Jennifer J. Gassman,Tom Greene,Milena Radeva,Gregory Braden,T. Alp Ikizler,Michael V. Rocco,Ingemar Davidson,James S. Kaufman,Catherine M. Meyers,John W. Kusek,Harold I. Feldman +18 more
TL;DR: Clopidogrel reduces the frequency of early thrombosis of new arteriovenous fistulas but does not increase the proportion of fistulas that become suitable for dialysis.
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
Laura M. Dember,Gerald J. Beck,Michael Allon,James A. Delmez,Bradley S. Dixon,Arthur Greenberg,Jonathan Himmelfarb,Miguel A. Vazquez,Jennifer J. Gassman,Tom Greene,Milena Radeva,Gregory Braden,T. Alp Ikizler,Michael V. Rocco,Ingemar Davidson,James S. Kaufman,Catherine M. Meyers,John W. Kusek,Harold I. Feldman +18 more
TL;DR: In this article, the Dialysis Access Consortium (DACA) study group presented a study of the Dialysysmosis Access Consortium and its relationships with the following physicians:Laura M. Dember, MDGerald J. Beck, PhDMichael Allon, MDJames A. Delmez, MDBradley S. Dixon, MDArthur Greenberg, MDJonathan Himmelfarb, MDMiguel A. Vazquez, MDJennifer J. Radeva, MSGregory L. Braden, MDT.
Journal ArticleDOI
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
Robert C. Atkins,Esther M. Briganti,Julia B. Lewis,Lawrence G. Hunsicker,Gregory Braden,Paul Champion de Crespigny,Giacomo Deferrari,Paul L. Drury,Francesco Locatelli,Thomas B. Wiegmann,Edmund J. Lewis +10 more
TL;DR: Baseline proteinuria is an important risk factor for kidney failure and provides a means to identify patients at greatest risk and proteinuria reduction using an angiotensin receptor-blocking agent, such as irbesartan, should be regarded as an important therapeutic goal in renoprotective strategies.
Journal ArticleDOI
Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions
Anthony E. Zimmermann,Thomas Pizzoferrato,John Bedford,Anne B. Morris,Anne B. Morris,Robert Hoffman,Gregory Braden,Gregory Braden +7 more
TL;DR: Tenofovir-associated ARF manifests as acute tubular necrosis that may not resolve with ten ofovir withdrawal that is associated with multiple drug interactions, leading to an increased risk of ARF.
Journal ArticleDOI
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Bradley S. Dixon,Gerald J. Beck,Miguel A. Vazquez,Arthur Greenberg,James A. Delmez,Michael Allon,Laura M. Dember,Jonathan Himmelfarb,Jennifer J. Gassman,Tom Greene,Milena Radeva,Ingemar Davidson,T. Alp Ikizler,Gregory Braden,Andrew Z. Fenves,James S. Kaufman,James R. Cotton,Kevin J. Martin,James W. McNeil,Asif Rahman,Jeffery H. Lawson,James F. Whiting,Bo Hu,Catherine M. Meyers,John W. Kusek,Harold I. Feldman +25 more
TL;DR: Treatment with dipyridamole plus aspirin had a significant but modest effect in reducing the risk of stenosis and improving the duration of primary unassisted patency of newly created grafts.